ArticleBioengineered2022

Serum miR-497-5p serves as a diagnostic biomarker for acute coronary syndrome and predicts the occurrence of major adverse cardiovascular events after percutaneous coronary intervention.

Tao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.